Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP708511.RAdmkzIxBHSP7oVdXxGchlQsn1yABTp5MIf1iooBA3R3A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP708511.RAdmkzIxBHSP7oVdXxGchlQsn1yABTp5MIf1iooBA3R3A130_assertion type Assertion NP708511.RAdmkzIxBHSP7oVdXxGchlQsn1yABTp5MIf1iooBA3R3A130_head.
- NP708511.RAdmkzIxBHSP7oVdXxGchlQsn1yABTp5MIf1iooBA3R3A130_assertion description "[However, regardless of greatly reduced mortality rates with BCR-ABL targeted therapy, most patients harbor quiescent CML stem cells that may be a reservoir for disease progression to blast crisis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP708511.RAdmkzIxBHSP7oVdXxGchlQsn1yABTp5MIf1iooBA3R3A130_provenance.
- NP708511.RAdmkzIxBHSP7oVdXxGchlQsn1yABTp5MIf1iooBA3R3A130_assertion evidence source_evidence_literature NP708511.RAdmkzIxBHSP7oVdXxGchlQsn1yABTp5MIf1iooBA3R3A130_provenance.
- NP708511.RAdmkzIxBHSP7oVdXxGchlQsn1yABTp5MIf1iooBA3R3A130_assertion SIO_000772 19074122 NP708511.RAdmkzIxBHSP7oVdXxGchlQsn1yABTp5MIf1iooBA3R3A130_provenance.
- NP708511.RAdmkzIxBHSP7oVdXxGchlQsn1yABTp5MIf1iooBA3R3A130_assertion wasDerivedFrom befree-2016 NP708511.RAdmkzIxBHSP7oVdXxGchlQsn1yABTp5MIf1iooBA3R3A130_provenance.
- NP708511.RAdmkzIxBHSP7oVdXxGchlQsn1yABTp5MIf1iooBA3R3A130_assertion wasGeneratedBy ECO_0000203 NP708511.RAdmkzIxBHSP7oVdXxGchlQsn1yABTp5MIf1iooBA3R3A130_provenance.